MBX Biosciences, Inc. MBX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s total liabilities & equity?
- MBX Biosciences, Inc. (MBX) reported total liabilities & equity of $452.7M in Q1 2026.
- How has MBX Biosciences, Inc.'s total liabilities & equity changed year-over-year?
- MBX Biosciences, Inc.'s total liabilities & equity increased by 84.1% year-over-year, from $245.93M to $452.7M.
- What is the long-term trend for MBX Biosciences, Inc.'s total liabilities & equity?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s total liabilities & equity has grown at a 113.9% compound annual growth rate (CAGR), from $84.18M to $385.14M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.